Shizuoka, Japan

Tetsu Saito


Average Co-Inventor Count = 6.4

ph-index = 6

Forward Citations = 113(Granted Patents)


Location History:

  • Shizuoka, JA (1976)
  • Shizuoka, JP (1981 - 1992)
  • Mishima, JP (1993)

Company Filing History:


Years Active: 1976-1993

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Tetsu Saito: Innovator in Pharmaceutical Chemistry

Introduction

Tetsu Saito is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. His work primarily focuses on the development of novel compounds with therapeutic applications.

Latest Patents

Among his latest patents, Saito has developed pyrazolo[1,5-a]pyridine-3-carboxylic acid derivatives. These compounds are represented by a specific formula and are characterized by various substituents, including hydrogen atoms and lower alkyl groups. The preparation process of these derivatives and their application as serotonin receptor antagonists are also detailed in his patents. Additionally, he has worked on the antibiotic L53-18A, which is useful for treating bacterial infections. This antibiotic is obtained through the cultivation of Saccharopolyspora sp. L53-18 in a suitable medium.

Career Highlights

Throughout his career, Tetsu Saito has been associated with notable companies, including Toyo Jozo Kabushiki Kaisha and Toyo Jozo Company, Ltd. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Saito has collaborated with several professionals in his field, including Naoki Muto and Masaru Otani. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Tetsu Saito's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…